1) Chen Shen, Hong Yue, Jianwen Pei, Xiaomin Guo, Tao Wang*,Junmin Quan* “Crystal structure of the death effector domains of caspase-8”BBRC,2015,463, 297–302.
2) Hong Yue, Feng Lu, Chen Shen,Junmin Quan* “Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway”Bioorg. Chem.2015,61, 21–27.
3) Hongmei Shan, Yanxia Shi,Junmin Quan*. “Identification of Green Tea Catechins as Potent Inhibitors of the Polo-Box Domain of Polo-Like kinase 1”ChemMedChem.2015,10, 158-163.
4) Hongmei Shan, Tao Wang*, Junmin Quan*. “Crystal structure of the Polo-box Domains of Polo-like Kinase 2”BBRC,2015,456, 780–784.
5) Jun Xu, Chen Shen, Tao Wang*,Junmin Quan* “Structural basis for the inhibition of Polo-like kinase 1”Nat. Struct. Mol. Biol.2013,20, 1047-53. (Highlighted in cover and also by Nature China, 2 October 2013 | doi:10.1038/nchina.2013.92)
6) Dai L, Liu Y, Liu J, Wen X, Xu Z, Wang Z, Sun H, Tang S, Maguire AR,Quan J*, Zhang H*, Ye T*. “A novel CyclinE/CyclinA-CDK Inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: Implications in cancer therapy.”Cancer Lett.2013,333, 103-112.
7) Jing Wang, Fei Lu, Qi Ren, Hong Sun, Zhengshuang Xu, Rongfeng Lan, Yuqing Liu, David Ward,Junmin Quan*, Tao Ye*, Hui Zhang*. “Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties”Cancer Res.2011,71, 7238-49. (Highlighted by Nature China, 4 January 2012 | doi:10.1038/nchina.2012.1)
8) Xiaolei Wang,Junmin Quan*“Intermediate-Assisted Multifunctional Catalysis in the Conversion of Flavin to 5,6-Dimethylbenzimidazole by BluB: A Density Functional Theory Study”J.Am. Chem. Soc.2011,133, 4079-4091.
9) Lintai Da,Junmin Quan*, YunDong Wu* “Understanding the binding mode and function of BMS-488043 against HIV-1 viral entry”Proteins: Struct., Funct., Bioinf.2011,79, 1810-1819.
10) Haixia Zou, Liyan Zhou, Yuanzhen Li, Hanbing Zhong, Zhengying Pan, Zhen Yang,Junmin Quan*“Benzo[e]isoindole-1,3-diones as Potential Inhibitors of Glycogen Synthase Kinase-3 (GSK-3). Synthesis, Kinase Inhibitory Activity, Zebrafish Phenotype”J. Med. Chem.2010,53, 994-1003.
